Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case series. Chisari CG, Toscano S, Arena S, Finocchiaro C, et al. BMC Neurol 2021;21:462.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chisari CG, Toscano S, Arena S, Finocchiaro C, et al. Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case series. BMC Neurol 2021;21:462.
PMID: 34839814